This multicenter case series reports the short-term outcomes of arthroscopic superior capsule reconstruction using dermal allograft for irreparable massive rotator cuff tears. It asks whether a dermal allograft, rather than fascia lata autograft, produces meaningful functional improvement in this difficult population.
When you face an irreparable massive cuff tear in a patient too young for reverse arthroplasty, SCR is a joint-preserving option, but patient selection determines results. The practical decision rule from this paper: reserve SCR for Hamada 1 or 2 shoulders and avoid it once acetabularization (Hamada 3) or glenohumeral narrowing (Hamada 4) has developed.
Graft healing is the central variable. A healed graft gave 100% success, a failed graft under 50%, so anything that promotes healing (adequate graft thickness, competent subscapularis) is worth protecting. Use a 3 mm graft, not a thin one, and be cautious in patients with Goutallier grade 3 or 4 subscapularis atrophy.
Read this as Level IV evidence with low MRI follow-up and no comparison group. It establishes indications and healing as prognostic factors, not that SCR is a durable long-term solution.
This multicenter case series reports the short-term outcomes of arthroscopic superior capsule reconstruction using dermal allograft for irreparable massive rotator cuff tears. It asks whether a dermal allograft, rather than fascia lata autograft, produces meaningful functional improvement in this difficult population.
When you face an irreparable massive cuff tear in a patient too young for reverse arthroplasty, SCR is a joint-preserving option, but patient selection determines results. The practical decision rule from this paper: reserve SCR for Hamada 1 or 2 shoulders and avoid it once acetabularization (Hamada 3) or glenohumeral narrowing (Hamada 4) has developed.
Graft healing is the central variable. A healed graft gave 100% success, a failed graft under 50%, so anything that promotes healing (adequate graft thickness, competent subscapularis) is worth protecting. Use a 3 mm graft, not a thin one, and be cautious in patients with Goutallier grade 3 or 4 subscapularis atrophy.
Read this as Level IV evidence with low MRI follow-up and no comparison group. It establishes indications and healing as prognostic factors, not that SCR is a durable long-term solution.